Indian Pharma Faces Limited Impact from US Tariffs on Patented Medicines
The announcement by Donald J Trump to impose a 100 Percent tariff on patented pharmaceuticals and their ingredients is expected to have a limited immediate impact on the Indian pharmaceutical industry, according to industry experts.
Indian Pharma | 04/04/2026 | By Darshana
Indian Pharma Firms Selected to Supply Key Generic Drugs in China
Several Indian pharmaceutical companies—including Cipla Ltd, Hetero Labs Limited, Natco Pharma Limited, and Annora Pharma Private Limited—have won bids to supply generic medicines to public hospitals in China under the country’s volume-based procurement (VBP) programme.
Indian Pharma | 12/11/2025 | By Darshana | 474
India’s small and mid-sized pharmaceutical manufacturers are raising alarms over new good manufacturing practice (GMP) and bio-equivalence mandates, warning that the regulations could widen the gap between large companies and micro, small, and medium enterprises (MSMEs).
Indian Pharma | 13/10/2025 | By Darshana | 576
PM Narendra Modi lays foundation stone of bulk drug park in Una, HP
Raw materials for medicine manufacturing will be produced in Himachal Pradesh
Indian Pharma | 13/10/2022 | By Sudeep Soparkar | 441
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy